Curated Resources — Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview

Below is a working bibliography of trusted health, pharmacovigilance, and legal-analysis sources, compiled for open research.

Recommended deep-dive

Tysabri Progressive Multifocal Leukoencephalopathy lawsuit eligibility overview: Key Facts & Context — detailed background and analysis.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.